Colorectal cancer liver metastases: Genomics and biomarkers with focus on local therapies

Y Kitsel, T Cooke, V Sotirchos, CT Sofocleous - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer (CRC) is a leading cause of death among cancer
patients, and the liver is the most common visceral metastatic site. Despite promising …

[HTML][HTML] Colorectal cancer liver metastasis: evolving paradigms and future directions

LR Zarour, S Anand, KG Billingsley, WH Bisson… - Cellular and molecular …, 2017 - Elsevier
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key
goals for improving outcomes including early detection, effective prognostic indicators of …

The role of biomarkers in the management of colorectal liver metastases

DB Hewitt, ZJ Brown, TM Pawlik - Cancers, 2022 - mdpi.com
Simple Summary Colorectal cancer remains one of the most significant sources of cancer-
related morbidity and mortality worldwide. The liver is the most common site of metastatic …

Tailored systemic therapy for colorectal cancer liver metastases

C Czauderna, K Luley, N von Bubnoff… - International Journal of …, 2021 - mdpi.com
Liver metastases are the most common site of metastatic spread in colorectal cancer.
Current treatment approaches involve effective systemic therapies in combination with …

Proteomic profiling and biomarker discovery in colorectal liver metastases

GYM Wong, C Diakos, TJ Hugh, MP Molloy - International Journal of …, 2022 - mdpi.com
Colorectal liver metastases (CRLM) are the leading cause of death among patients with
metastatic colorectal cancer (CRC). As part of multimodal therapy, liver resection is the …

Emerging paradigms in the treatment of liver metastases in colorectal cancer

A Alhumaid, Z AlYousef, HA Bakhsh… - Critical Reviews in …, 2018 - Elsevier
Efforts to combat colorectal cancer have benefited from improved screening and
surveillance, which facilitates early detection. The survival rate associated with diagnosis at …

Colorectal liver metastases: does the future of precision medicine lie in genetic testing?

C Barbon, GA Margonis, N Andreatos, N Rezaee… - Journal of …, 2018 - Elsevier
Colorectal liver metastases (CRLM) present an important clinical challenge in both surgical
and medical oncology. Despite improvements in management, survival among patients …

[HTML][HTML] Is there a genetic signature for liver metastasis in colorectal cancer?

C Nadal, J Maurel, P Gascon - World journal of gastroenterology …, 2007 - ncbi.nlm.nih.gov
Even though liver metastasis accounts for the vast majority of cancer deaths in patients with
colorectal cancer (CRC), fundamental questions about the molecular and cellular …

Integrated Clinical-Molecular classification of Colorectal Liver metastases: a biomarker analysis of the phase 3 New EPOC Randomized Clinical Trial

RR Katipally, CA Martinez, SA Pugh… - JAMA …, 2023 - jamanetwork.com
Importance Personalized treatment approaches for patients with oligometastatic colorectal
liver metastases are critically needed. We previously defined 3 biologically distinct …

Personalized treatment in patients with colorectal liver metastases

D Moris, TM Pawlik - journal of surgical research, 2017 - Elsevier
Abstract Background Precision Medicine Initiative is a new research effort aiming to offer
personalized treatment in many diseases, including cancer. The aim of the present article is …